TY  - JOUR
T1  - GEne therapy for hearing loss
AU  - Hampton T
Y1  - 2012/09/05
N1  - 10.1001/2012.jama.10869
JO  - JAMA
SP  - 853
EP  - 853
VL  - 308
IS  - 9
N2  - 
Investigators at the University of California, San Francisco, and colleagues used mice with hereditary deafness caused by a mutation in the gene that encodes the vesicular glutamate transporter 3 (VGLUT3) protein, which is crucial for inner hair cells to send signals that enable hearing. Previous research indicates that a mutation in the human version of this gene may play a role in some cases of congenital hearing loss in people.

SN  - 0098-7484
M3  - doi: 10.1001/2012.jama.10869
UR  - http://dx.doi.org/10.1001/2012.jama.10869
ER  -